Keith W. Marshall


Dr. Marshall was appointed as the Chief Financial Officer in August 2020. Prior to joining Prometheus, Dr. Marshall served as Executive Vice President, Chief Operating Officer and Chief Financial Officer of Conatus Pharmaceuticals (Nasdaq: CNAT) since 2017. Prior to Conatus, he served as Chief Financial Officer and Head of Corporate Development ...

Roles at Prometheus Biosciences

  • CFO

    Current role

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at Prometheus Biosciences

My pet peeves

My communication style

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.